Ro vs Medvi: Telehealth Model, Compounding, and Pricing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This PlexusDx Education Hub review looks at a broad telehealth brand next to one built around compounded-pharmacy fulfillment. See the complete Peptides & GLP-1 collection.

Full head-to-head: PlexusDx vs MEDVi →

An independent editorial comparison: PlexusDx has no commercial relationship with Ro, earns no referral income here, and includes no affiliate links.

Ro and Medvi both sell GLP-1 weight care online, but they emphasize different parts of the supply chain. Ro leads with a familiar telehealth membership; Medvi foregrounds its compounding pathway. This editorial breaks down each model, explains what compounded dispensing means, and points to a genetic factor that sits outside both.

Comparing a broad telehealth brand with a compounding-focused one

The headline contrast here is structural. Ro is a wide-catalog telehealth company that treats weight as one category among many. Medvi Wellness positions itself around compounded GLP-1 preparations delivered through a pharmacy relationship. Same drug class, different center of gravity.

Ro's model in brief

Ro (Roman Health) runs on subscription telehealth: an online evaluation, a clinician's prescription, and dispensing that may involve a retail or compounding pharmacy depending on the product. Because plans and pricing shift, verify specifics at Ro's official website.

Medvi and the compounded-pharmacy pathway

Medvi (Medvi Wellness) combines telehealth with compounded pharmacy fulfillment. Its medication options, program structure, and prices vary and are best confirmed directly at Medvi's official website as of the day you read this.

What 503A compounding actually means

Compounded GLP-1 medications are prepared by state-licensed 503A compounding pharmacies for an individual patient's prescription, rather than manufactured as an FDA-approved branded product. This is a distinct regulatory lane. When a program like Medvi leans on compounding, the questions worth asking are about pharmacy licensure and clinician oversight — the same standards any legitimate program should meet.

Pricing logic when compounding is central

Across the market as of April 2026, monthly GLP-1 telehealth spend generally runs from about $200 to $700+ once program fees, medication, and compounding are combined. A compounding-centric program may structure its costs differently from a broad telehealth catalog, but both publish their own figures and both revise them. Read each brand's live pricing page rather than trusting a fixed number.

Evidence behind the molecules

No matter the fulfillment route, the biology traces to the compound. GLP-1 receptor agonists — semaglutide, liraglutide, dulaglutide — and the dual GIP/GLP-1 agonist tirzepatide influence satiety, appetite signaling, and gastric emptying. Trial support is deep: STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide in obstructive sleep apnea, NEJM 2024). Effect sizes track with dose, compound, and person.

The upstream variable: your metabolic genetics

Neither a compounded nor a branded prescription accounts for your inherited metabolic baseline. Markers in TCF7L2, tied to glucose regulation and GLP-1 secretion, join GLP1R — the receptor each of these compounds binds — along with FTO and MC4R in the appetite and energy-balance system. These sit at the pathway level: descriptive of the terrain, not predictive of any single drug's outcome.

PlexusDx dispenses semaglutide and tirzepatide within its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Ahead of any protocol, the Precision Peptide Genetic Test examines 14 pathways, 49 peptides, 150+ genetic insights across FTO and MC4R, and TCF7L2 — the test-before-you-invest approach that turns assumptions into an informed provider discussion.

Not affiliated: PlexusDx is not affiliated with Ro and holds no commercial relationship with any company reviewed here.

More from the PlexusDx library: GLP 1 Hormone, What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist.

Disclaimer: This article is educational. PlexusDx is not affiliated with Ro and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways — it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare directly: view the Weight Management Protocols for semaglutide and tirzepatide with genetic context, or start with the Precision Peptide Genetic Test.

Frequently Asked Questions

Is a compounding-focused program like Medvi safer or riskier than Ro?

Neither is inherently safer. Safety hinges on the same markers for both: state-licensed pharmacy partners, appropriate clinician oversight, and clinical evaluation before any prescription. A compounding emphasis simply means the 503A pathway is more central, so confirm licensure and review standards directly with the program.

What is a 503A compounded GLP-1 medication?

It is a semaglutide or tirzepatide preparation made by a state-licensed compounding pharmacy for a specific patient's prescription, rather than an FDA-approved branded product. The compound class and mechanism are the same; the regulatory pathway and preparation process differ from mass-manufactured medications sold at retail.

Does the Precision Peptide Genetic Test evaluate compounded medications?

No. It does not assess any medication, compounded or branded, and it does not predict drug response. It reads pathway-level markers such as TCF7L2, FTO that describe your baseline metabolic biology, independent of whichever pharmacy pathway ultimately fills a given prescription.

How is PlexusDx different from Ro and Medvi?

PlexusDx offers semaglutide and tirzepatide protocols alongside the Precision Peptide Genetic Test. The distinguishing element is pathway-level genetic insight into FTO, MC4R — context that a telehealth or compounding program typically does not provide together with the medication itself.

This article is part of the PlexusDx Education Hub. Browse more Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.